← Back
$IONS All transactions

IONIS PHARMACEUTICALS INC

▼ SELL 10b5-1 Plan

$ Value

$16K

Shares

200

Price

$80

Filed

Mar 5

Insider

Name

LOSCALZO JOSEPH

Title

CIK

0001276128

Roles

Director

Transaction Details

Transaction Date

2026-03-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

36,330

Footnotes

Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 18, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.035 to $81.01 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.

Filing Info

Accession No.

0000874015-26-000138

Form Type

4

Issuer CIK

0000874015

LOSCALZO JOSEPH's History

Date Ticker Type Value
2026-03-13 CYPH M
2026-03-13 CYPH M
2026-03-13 CYPH M $0
2026-03-13 CYPH M $0
2026-03-04 IONS M $8K
2026-03-04 IONS $16K
2026-03-04 IONS M $0
2026-03-03 IONS M $32K
2026-03-03 IONS $67K
2026-03-03 IONS M $0

Other Insiders at IONS (90d)

Insider Bought Sold Last
PARSHALL B LYNNE $795K 2026-04-15
BENNETT C FRANK
EVP, Chief Scientific Officer
$14.3M 2026-03-03
HOUGEN ELIZABETH L
EVP, Finance & CFO
$582K 2026-01-30
KLEIN JOSEPH III $3.4M 2026-04-01
LOSCALZO JOSEPH $67K 2026-03-04
Monia Brett P
Chief Executive Officer
$19.8M 2026-03-10
O'NEIL PATRICK R.
EVP CLO & General Counsel
$1.3M 2026-03-09
Diaz Allene M. $4.4M 2026-03-03
Swayze Eric
EVP Research
$1.8M 2026-02-27
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
$3.2M 2026-04-16
Baroldi Joseph
EVP, Chief Business Officer
$1.4M 2026-04-16
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
$516K 2026-01-30
Birchler Brian
EVP, Corp and Development Ops
$586K 2026-04-16
Devers Shannon L.
EVP, Chief Human Resources Ofc
$2.1M 2026-04-02